Confluence Life Sciences
acquired by Aclaris TherapeuticsSaint Louis, US · Delaware corporation · 1 known investors
Technology-focused company on rational drug design for cancer and chronic inflammatory diseases (acquired by Aclaris Therapeutics in August 2017).
Healthtech
Founders & leadership
DJ
Daniel JaniakDirector
JB
Jennifer BohnertExecutive Officer
WS
Walter SmithExecutive Officer, Director
JM
Joseph MonahanExecutive Officer, Director
CB
Charles BoltenDirector
TS
Thomas SmartDirector
KS
Kyparissia SirinakisDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$4.8MraisedApr 2016 · 16 investors · Other Health CareRule 506(b)
▶$4.8MraisedApr 2016 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel JaniakDirector
- Jennifer BohnertExecutive Officer
- Walter SmithExecutive Officer, Director
- Joseph MonahanExecutive Officer, Director
- Charles BoltenDirector
- Thomas SmartDirector
- Kyparissia SirinakisDirector
- Offering amount
- $5.4M
- Amount sold
- $4.8M
- Minimum investment
- $1
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.